Balchem Corp

Research Balchem Corp (BCPC) on Bullrun: valuation model: 8.2% overvalued, market cap USD 5.74B, P/E 35.3, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Balchem Corp as 8.2% overvalued; latest market cap is USD 5.74B; P/E is 35.3; dividend yield is 0.5%.

Peer valuation comparison

Latest P/E is 35.31x versus a Basic Materials sector median of 17.36x (103.4% above).

Latest dividend yield is 0.54% versus a Basic Materials sector median of 2.19% (75.3% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 1.04BUSD 154.85MUSD 173.07M35.7%4.75USD 74.57MUSD 180.69MUSD 1.26B
FY2024USD 953.68MUSD 128.48MUSD 146.34M35.3%3.93USD 49.52MUSD 208.04MUSD 1.15B
FY2023USD 922.44MUSD 108.54MUSD 146.06M32.7%3.35USD 64.45MUSD 330.33MUSD 1.05B
FY2022USD 942.36MUSD 105.37MUSD 89.45M29.8%3.25USD 66.56MUSD 446.68MUSD 938.28M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 5.74B35.30.5%0.96
20252025-12-31USD 4.92B32.30.6%0.96
20242024-12-31USD 5.30B41.50.5%0.87
20232023-12-29USD 4.80B46.60.5%0.79
20222022-12-30USD 3.92B36.30.6%0.71
20212021-12-31USD 5.44B57.30.4%0.64

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.96 USD, yield 0.5%.

YearDividends/share
FY20250.96 USD
FY20240.87 USD
FY20230.79 USD
FY20220.71 USD

About Balchem Corp

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Related stock research

Other Basic Materials stocks

Frequently asked questions

Is Balchem Corp overvalued or undervalued?

Bullrun's valuation model currently marks Balchem Corp as 8.2% overvalued.

What is Balchem Corp's market cap?

Balchem Corp's market capitalization is USD 5.74B.

What is Balchem Corp's P/E ratio?

Balchem Corp's price-to-earnings (P/E) ratio is 35.3.

Does Balchem Corp pay a dividend?

Balchem Corp has a dividend yield of 0.5%.

What does Balchem Corp do?

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.